Hence, an increase in REDD1 expression was observed in patients with Parkinson’s disease [16], and dopaminergic neurotoxin 6-OHDA upregulated REDD1 in vitro [17] and in vivo [18]. Here, DDIT4 is linked to Parkinson disease.